XML 37 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity (Tables)
 9 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Schedule of Stock Options Activity
The following table summarizes stock option activity under the Equity Plans for the nine months ended June 30, 2018:


Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average
Remaining Contractual Life
(in years)
 
Aggregate Intrinsic Value (*) (in thousands)
Outstanding as of September 30, 2017
326,798

 
$19.54
 
 
 
 
Granted
—

 
—

 
 
 
 
Exercised
(4,831
)
 
$4.32
 
 
 
$
14

Forfeited
(4,944
)
 
$4.36
 
 
 
 
Expired
(242,979
)
 
$24.66
 
 
 
 
Outstanding as of June 30, 2018
74,044

 
$4.74
 
5.32
 
$
45

Exercisable as of June 30, 2018
45,129

 
$4.70
 
4.08
 
$
33

Vested and expected to vest as of June 30, 2018
74,044

 
$4.74
 
5.32
 
$
45


(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option's exercise price and the underlying stock price. For the nine months ended June 30, 2017, the intrinsic value of options exercised was $0.9 million.
Schedule of Restricted Stock Activity
The following table summarizes the activity related to RSUs and RSAs subject to time-based vesting requirements for the nine months ended June 30, 2018:

Restricted Stock Activity
 
Restricted Stock Units
 
Restricted Stock Awards
 
Number of Shares
 
Weighted Average Grant Date Fair Value
 
Number of Shares
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2017
 
778,084

 
$5.91
 
8,154

 
$8.20
Granted
 
643,043

 
$5.81
 
—

 
$0.00
Vested
 
(370,281
)
 
$5.40
 
—

 
$0.00
Forfeited
 
(22,854
)
 
$5.23
 
—

 
$0.00
Non-vested as of June 30, 2018
 
1,027,992

 
$6.05
 
8,154

 
$8.20
Schedule of Performance Share Activity
The following table summarizes the activity related to PSUs and PRSAs for the nine months ended June 30, 2018:

Performance Stock Activity
 
Performance Stock Units
 
Performance Stock Awards
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2017
 
328,708

 
$8.36
 
33,333

 
$12.25
Granted
 
240,164

 
$7.62
 
—

 
$0.00
Vested
 
(166,058
)
 
$6.86
 
—

 
$0.00
Forfeited
 
(5,037
)
 
$13.36
 
—

 
$0.00
Non-vested as of June 30, 2018
 
397,777

 
$8.48
 
33,333

 
$12.25
Schedule of Stock-based Compensation Expense - By Award Type
The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense - by award type
For the three months ended June 30,
 
For the nine months ended June 30,
(in thousands)
2018
 
2017
 
2018
 
2017
Employee stock options
$
6

 
$
12

 
$
26

 
$
34

Restricted stock units and awards
400

 
488

 
1,263

 
1,211

Performance stock units and awards
330

 
410

 
980

 
1,049

Employee stock purchase plan
64

 
92

 
225

 
210

Outside director equity awards and fees in common stock
65

 
78

 
219

 
168

Total stock-based compensation expense
$
865

 
$
1,080

 
$
2,713

 
$
2,672
Schedule of Stock-based Compensation Expense - By Expense Type
Stock-based Compensation Expense - by expense type
For the three months ended June 30,
 
For the nine months ended June 30,
(in thousands)
2018
 
2017
 
2018
 
2017
Cost of revenue
$
83

 
$
113

 
$
337

 
$
353

Selling, general, and administrative
625

 
824

 
1,915

 
1,957

Research and development
157

 
143

 
461

 
362

Total stock-based compensation expense
$
865

 
$
1,080

 
$
2,713

 
$
2,672
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted net (loss) income per share:

Basic and Diluted Net (Loss) Income Per Share
 
For the three months ended June 30,
 
For the nine months ended June 30,
(in thousands, except per share)
 
2018
 
2017
 
2018
 
2017
Numerator:
 
 
 
 
 
 
 
 
   (Loss) income from continuing operations
 
$
(8,414
)
 
$
2,436

 
$
(11,567
)
 
$
6,057

   Loss from discontinued operations
 
—

 
(11
)
 
—

 
(27
)
Undistributed earnings allocated to common shareholders for basic and diluted net income per share
 
(8,414
)
 
2,425

 
(11,567
)
 
6,030

Denominator:
 
 
 
 
 
 
 
 
Denominator for basic net income per share - weighted average shares outstanding
 
27,387

 
26,833

 
27,204

 
26,577

Dilutive options outstanding, unvested stock units, unvested stock awards and ESPP
 
—

 
983

 
—

 
971

Denominator for diluted net income per share - adjusted weighted average shares outstanding
 
27,387

 
27,816

 
27,204

 
27,548

 
 
 
 
 
 
 
 
 
Net (loss) income per basic share:
 
 
 
 
 
 
 
 
   Continuing operations
 
$
(0.31
)
 
$
0.09

 
$
(0.43
)
 
$
0.23

   Discontinued operations
 
—

 
(0.00
)
 
—

 
(0.00
)
Net (loss) income per basic share
 
$
(0.31
)
 
$
0.09

 
$
(0.43
)
 
$
0.23

 
 
 
 
 
 
 
 
 
Net (loss) income per diluted share:
 
 
 
 
 

 

   Continuing operations
 
$
(0.31
)
 
$
0.09

 
$
(0.43
)
 
$
0.22

   Discontinued operations
 
—

 
(0.00
)
 
—

 
(0.00
)
Net (loss) income per diluted share
 
$
(0.31
)
 
$
0.09

 
$
(0.43
)
 
$
0.22

Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation
 
825

 
370

 
725

 
400

 
 
 
 
 
 
 
 
 
Average market price of common stock
 
$
5.06

 
$
10.00

 
$
6.20

 
$
8.66
Schedule of Common Stock Reserved for Future Issuances
As of June 30, 2018, we had common stock reserved for the following future issuances:
Future Issuances
Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options
74,044

Unvested restricted stock units
1,027,992

Unvested performance stock units (at 200% maximum payout)
795,554

Purchases under the employee stock purchase plan
818,036

Issuance of stock-based awards under the Equity Plans
1,493,848

Purchases under the officer and director share purchase plan
88,741

Total reserved
4,298,215